Class information for:
Level 2: SGLT2 INHIBITOR//DAPAGLIFLOZIN//CANAGLIFLOZIN

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
1637 6442 34.8 57%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 3)


ID, lev.
above		 Publications Label for level above
316 35223 P GLYCOPROTEIN//MULTIDRUG RESISTANCE//SGLT2 INHIBITOR

Classes in level below (level 1)


ID, lev. below Publications Label for level below
6676 1383 BIOL PROF E CAVIEDES CODELIA//GLUT5//MULTIDISCIPLINARIO INVEST BIOL SAN LUIS
6752 1373 NA P I COTRANSPORT//PHOSPHATE TRANSPORT//NAPI IIA
8711 1157 SGLT2 INHIBITOR//DAPAGLIFLOZIN//CANAGLIFLOZIN
10471 994 ATLANTIC WHITE SHRIMP//RAPID FILTRATION TECHNIQUE//NADC1
13582 762 MITOCHONDRIAL OXIDATIVE ENZYMES//INSERM U319//RENAL CULTURED CELLS
17867 515 AMMONIAGENESIS//CELLULAR GLUTAMATE//RABBIT KIDNEY CORTEX TUBULES
29435 152 NA ATPASE//SECOND SODIUM PUMP//ANG 3 4
32541 106 POLYUNSATURATED FREE FATTY ACID//BRUSH BORDERS//ISF PHARM

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SGLT2 INHIBITOR Author keyword 284 94% 2% 103
2 DAPAGLIFLOZIN Author keyword 253 92% 2% 98
3 CANAGLIFLOZIN Author keyword 164 89% 1% 74
4 SGLT2 Author keyword 160 86% 1% 81
5 EMPAGLIFLOZIN Author keyword 118 90% 1% 52
6 SGLT1 Author keyword 62 49% 1% 93
7 URINARY GLUCOSE EXCRETION Author keyword 62 92% 0% 24
8 IPRAGLIFLOZIN Author keyword 45 90% 0% 19
9 SGLT2 INHIBITORS Author keyword 44 77% 0% 30
10 SODIUM GLUCOSE CO TRANSPORTER 2 SGLT2 INHIBITOR Author keyword 41 100% 0% 15

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 SGLT2 INHIBITOR 284 94% 2% 103 Search SGLT2+INHIBITOR Search SGLT2+INHIBITOR
2 DAPAGLIFLOZIN 253 92% 2% 98 Search DAPAGLIFLOZIN Search DAPAGLIFLOZIN
3 CANAGLIFLOZIN 164 89% 1% 74 Search CANAGLIFLOZIN Search CANAGLIFLOZIN
4 SGLT2 160 86% 1% 81 Search SGLT2 Search SGLT2
5 EMPAGLIFLOZIN 118 90% 1% 52 Search EMPAGLIFLOZIN Search EMPAGLIFLOZIN
6 SGLT1 62 49% 1% 93 Search SGLT1 Search SGLT1
7 URINARY GLUCOSE EXCRETION 62 92% 0% 24 Search URINARY+GLUCOSE+EXCRETION Search URINARY+GLUCOSE+EXCRETION
8 IPRAGLIFLOZIN 45 90% 0% 19 Search IPRAGLIFLOZIN Search IPRAGLIFLOZIN
9 SGLT2 INHIBITORS 44 77% 0% 30 Search SGLT2+INHIBITORS Search SGLT2+INHIBITORS
10 SODIUM GLUCOSE CO TRANSPORTER 2 SGLT2 INHIBITOR 41 100% 0% 15 Search SODIUM+GLUCOSE+CO+TRANSPORTER+2+SGLT2+INHIBITOR Search SODIUM+GLUCOSE+CO+TRANSPORTER+2+SGLT2+INHIBITOR

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 NA GLUCOSE COTRANSPORTER 235 60% 4% 259
2 DAPAGLIFLOZIN 230 81% 2% 138
3 SGLT2 INHIBITOR 229 92% 1% 91
4 INADEQUATE GLYCEMIC CONTROL 161 70% 2% 135
5 SELECTIVE SGLT2 INHIBITOR 118 90% 1% 52
6 COTRANSPORTER 2 INHIBITOR 106 95% 1% 36
7 P I COTRANSPORTER 100 83% 1% 57
8 T 1095 99 97% 0% 29
9 GALACTOSE MALABSORPTION 96 91% 1% 40
10 PHLORIZIN BINDING 85 89% 1% 39

Journals


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 RENAL PHYSIOLOGY AND BIOCHEMISTRY 5 10% 1% 50
2 CONTRIBUTIONS TO NEPHROLOGY 3 14% 0% 20

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Biology of Human Sodium Glucose Transporters 2011 176 221 72%
Pharmacodynamics, Efficacy and Safety of Sodium-Glucose Co-Transporter Type 2 (SGLT2) Inhibitors for the Treatment of Type 2 Diabetes Mellitus 2015 8 134 93%
SGLT2 inhibition - a novel strategy for diabetes treatment 2010 130 27 85%
Renal Na+-glucose cotransporters 2001 278 66 82%
Sodium-Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes A Systematic Review and Meta-analysis 2013 73 35 80%
Proximal tubular phosphate reabsorption: Molecular mechanisms 2000 242 358 72%
Blood pressure effects of sodium-glucose co-transport 2 (SGLT2) inhibitors 2014 17 34 94%
Familial Renal Glucosuria and SGLT2: From a Mendelian Trait to a Therapeutic Target 2010 79 62 82%
Phlorizin: a review 2005 270 67 46%
Clinical Pharmacokinetics and Pharmacodynamics of Dapagliflozin, a Selective Inhibitor of Sodium-Glucose Co-transporter Type 2 2014 19 25 80%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 BIOL PROF E CAVIEDES CODELIA 18 65% 0.3% 17
2 MULTIDISCIPLINARIO INVEST BIOL SAN LUIS 14 64% 0.2% 14
3 TIANJIN MOL DESIGN DRUG DISCOVERY 7 27% 0.4% 23
4 PROD PLANNING COORDINAT 6 71% 0.1% 5
5 EPITHELIAL FUNCT DEV GRP 6 37% 0.2% 13
6 EPITHELIAL CELL PHYSIOL 6 50% 0.1% 8
7 NUTR METAB GRP 5 17% 0.4% 28
8 DRUG RAT 5 55% 0.1% 6
9 MOL NUTR 4 17% 0.4% 23
10 BIOQUIM RENAL 4 75% 0.0% 3

Related classes at same level (level 2)


Rank Relatedness score Related classes
1 0.0000026659 PEPT1//PEPT2//HPEPT1
2 0.0000021344 SUCRASE ISOMALTASE//CDX2//EPIMORPHIN
3 0.0000018536 KCC2//ENAC//EPITHELIAL SODIUM CHANNEL
4 0.0000017854 GLUTAMATE TRANSPORTER//CYSTINURIA//GLT 1
5 0.0000013007 VASCULAR CALCIFICATION//FGF 23//CALCIPHYLAXIS
6 0.0000012939 EZRIN//MOESIN//RADIXIN
7 0.0000012543 GLUCOSE TRANSPORTER//WARBURG EFFECT//GLUT1
8 0.0000012461 GENTAMICIN//WEN PI TANG//GENTAMICIN INDUCED NEPHROTOXICITY
9 0.0000008242 CLAUDIN//TIGHT JUNCTION//OCCLUDIN
10 0.0000007350 ACHONDROPLASIA//HYPOCHONDROPLASIA//THANATOPHORIC DYSPLASIA